Ashley Yeo
Executive Editor, MTI; Medtech Editor, In Vivo
Ashley has reported on health care market issues with Citeline and legacy companies since 1988, initially as a linguist on the France and Germany desk and later becoming editor of three titles. Two publications are his current focus for written and multimedia (panel moderating and podcasts) content: In Vivo (global medtech market access); and Medtech Insight (regulation and policy content for the UK, European and Asia markets).
Latest From Ashley Yeo
What A Patient Wants: Insights From ZS’s ‘Future Of Health’
If artificial intelligence and connected care are the answer to growing demand for care from health systems under pressure, why is the question apparently falling on deaf ears? ZS principal Brian Chapman sums up the state of play.
AMR, UTI, Breathomics And 3D Printing Technology Innovators Profiled At BioWales 2024
Breathomics, UTI diagnosis and advanced wound healing innovations were among the center stage technologies at BioWales in London 2024. Hear from CEO John McKinley on Imspex Diagnostics' plans in embedded podcast.
Clinicians: ‘Show Me The Impact And Outcomes Of AI Tools’
Royal Philips’ ninth annual Future Health Index global report reveals a growing acceptance by clinicians and health care stakeholders of virtual care and AI-enabled innovation. These tools can address workforce shortages, financial burdens and growing demand for care, said chief innovation and strategy officer Shez Partovi.
Therapeutic Endoscopy: ‘We’re At The Start Of What’s Possible’
In the emerging field of therapeutic endoscopy, Creo Medical’s Speedboat devices are advancing minimally invasive treatment by combining advanced bipolar radiofrequency and super high frequency microwave energy in a single device, says CTO and founder Chris Hancock.
16 Key Trends Reshaping The Future Of Medtech
Record attendance at the 2024 MedTech Forum in Vienna heard industry leaders voice optimism grounded in realism about future developments for Europe’s medtech industry, markets and delivery of care to patients. In Vivo filtered out 16 trends to watch.
Moving Towards A Total Lifecycle Regulatory Approach For AI Devices
Proportionately regulating highly adaptive AI as a medical device can be done with predetermined change control plans. The US, UK and Canada are advancing the concept, as Ropes & Gray and the US FDA explained.